These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15861523)

  • 41. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
    Secin FP; Bianco FJ; Vickers AJ; Reuter V; Wheeler T; Fearn PA; Eastham JA; Scardino PT
    Cancer; 2006 Jun; 106(11):2369-75. PubMed ID: 16649221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seminal vesicle amyloidosis does not provide any protection from invasion by prostate cancer.
    Erbersdobler A; Kollermann J; Graefen M; Röcken C; Schlomm T
    BJU Int; 2009 Feb; 103(3):324-6. PubMed ID: 18778344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
    BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comments to the manuscript: Survival after radical prostatectomy in patient with prostate cancer and seminal vesicle invasion].
    Sulkes A
    Rev Invest Clin; 2009; 61(2):181; author reply 182. PubMed ID: 19637732
    [No Abstract]   [Full Text] [Related]  

  • 45. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases.
    Ali TZ; Epstein JI
    Am J Surg Pathol; 2007 May; 31(5):697-705. PubMed ID: 17460452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer.
    Guzzo TJ; Vira M; Wang Y; Tomaszewski J; D'amico A; Wein AJ; Malkowicz SB
    J Urol; 2006 Feb; 175(2):518-21; discussion 521-2. PubMed ID: 16406985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
    Shariat SF; Roehrborn CG; McConnell JD; Park S; Alam N; Wheeler TM; Slawin KM
    J Clin Oncol; 2007 Feb; 25(4):349-55. PubMed ID: 17264329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer.
    Yamamoto S; Kawakami S; Yonese J; Fujii Y; Tsukamoto T; Ohkubo Y; Komai Y; Ishikawa Y; Fukui I
    Urology; 2008 Dec; 72(6):1224-8. PubMed ID: 18723208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic parameters other than Gleason score for the daily evaluation of prostate cancer in needle biopsy.
    Algaba F; Arce Y; Oliver A; Barandica C; Santaularia JM; Montañés R
    Eur Urol; 2005 Oct; 48(4):566-71. PubMed ID: 16084008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.
    Masterson TA; Pettus JA; Middleton RG; Stephenson RA
    Urology; 2005 Jul; 66(1):152-5. PubMed ID: 15992904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O; Eggener SE; Bianco FJ; Carver BS; Serio A; Scardino PT; Eastham JA
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.
    Loeb S; Roehl KA; Yu X; Antenor JA; Han M; Gashti SN; Yang XJ; Catalona WJ
    Urology; 2006 Jul; 68(1):99-103. PubMed ID: 16806410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML
    J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer.
    Horinaga M; Okita H; Nakashima J; Kanao K; Sakamoto M; Murai M
    Urology; 2005 Sep; 66(3):671-5. PubMed ID: 16140113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invasion of bladder neck after radical prostatectomy: one definition for different outcomes.
    Rodriguez-Covarrubias F; Larré S; Dahan M; De La Taille A; Allory Y; Yiou R; Vordos D; Hoznek A; Abbou CC; Salomon L
    Prostate Cancer Prostatic Dis; 2008; 11(3):294-7. PubMed ID: 17876340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K
    Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.